Literature DB >> 34807637

Interpersonal distancing preferences, touch behaviors to strangers, and country-level early dynamics of SARS-CoV-2 spread.

Agnieszka Sorokowska1, Supreet Saluja2, Konstantinos Kafetsios3, Ilona Croy4.   

Abstract

The recent Coronavirus Disease 2019 (COVID-19) pandemic has led to "social distancing" recommendations from public health organizations, as physical closeness bears the risk of person-to-person Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) transmission. Here, it was explored if interpersonal distance preferences and touch behaviors in 41 countries were valid measures of physical distancing in contacts between strangers and whether they related to country-level variation in early dynamics of SARS-CoV-2 spread. The analysis, based on aggregated data from more than 9,000 participants, showed that variation in early dynamics of SARS-CoV-2 spread (i.e., total number of SARS-CoV-2 cases 20 days after the 100th case) was significantly and positively related to nonaffective touch behaviors between strangers, and significantly and negatively related to the preferred interpersonal distance between strangers. These findings suggest that the two measures are suitable for monitoring the extent to which recommendations on physical distance are implemented at the country-level in the context of COVID 19 outbreak. Further, they confirm that "physical distancing" is related to the dynamics of the COVID-19 pandemic. It seems that an adaptation of social behaviors-that is, strict physical distancing from strangers-may result in a lower SARS-CoV-2 transmission rate. (PsycInfo Database Record (c) 2022 APA, all rights reserved).

Entities:  

Mesh:

Year:  2021        PMID: 34807637     DOI: 10.1037/amp0000919

Source DB:  PubMed          Journal:  Am Psychol        ISSN: 0003-066X


  1 in total

1.  Face masks reduce interpersonal distance in virtual reality.

Authors:  Leon O H Kroczek; Stephanie Böhme; Andreas Mühlberger
Journal:  Sci Rep       Date:  2022-02-09       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.